What Intelligent Bio Solutions Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 8 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 81,000 |
| Disposed | 0 | 0 |
| Net activity | +0 | +81,000 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Simeonidis Harry | Chief Executive Officer | Mar 18 | Grant / award · A | +21,350 | — | — | 34,540 |
| Simeonidis Harry | Chief Executive Officer | Mar 18 | Grant / award · A | +9,150 | — | — | 13,190 |
| Sakiris Spiro Kevin | Chief Financial Officer | Mar 18 | Grant / award · A | +21,350 | — | — | 33,981 |
| Sakiris Spiro Kevin | Chief Financial Officer | Mar 18 | Grant / award · A | +9,150 | — | — | 12,631 |
| Isenberg Jason | Director | Mar 18 | Grant / award · A | +5,000 | — | — | 5,000 |
| Hurd Jonathan Scott | Director | Mar 18 | Grant / award · A | +5,000 | — | — | 5,006 |
| Boyages Steven Constantine | Director | Mar 18 | Grant / award · A | +5,000 | — | — | 5,031 |
| Fraser Nicola Marion | Director | Mar 18 | Grant / award · A | +5,000 | — | — | 5,000 |
| Simeonidis Harry | Chief Executive Officer | Sep 25 | Grant / award · A | +40,000 | — | — | 40,408 |
| Sakiris Spiro Kevin | Chief Financial Officer | Sep 25 | Grant / award · A | +34,500 | — | — | 34,815 |
| Sakiris Spiro Kevin | Chief Financial Officer | Mar 20 | In/At-money Exercise · X | +9,394 | — | — | 19,180 |
| Towers Christopher | Director | Oct 04 | Open-market buy · P | +9,090 | — | — | 9,880 |
| Simeonidis Harry | CEO | Sep 01 | Open-market buy · P | +50 | $1.85 | +$92.5 | 4,180 |
| Simeonidis Harry | CEO | Aug 31 | Open-market buy · P | +100 | $1.92 | +$192 | 4,130 |
| Sakiris Spiro Kevin | Chief Financial Officer | May 10 | Derivative Conversion · C | +2,399 | $5.80 | +$13.9K | 4,745 |
| Sakiris Spiro Kevin | Chief Financial Officer | Oct 10 | Grant / award · A | +75,000 | — | — | 125,228 |
| Boyages Steven Constantine | Interim CEO and Chairperson | Oct 10 | Grant / award · A | +75,000 | — | — | 75,000 |
| Margelis George | Director | Oct 10 | Grant / award · A | +15,000 | — | — | 15,000 |
| Towers Christopher | Director | Oct 10 | Grant / award · A | +15,000 | — | — | 15,800 |
| Hurd Jonathan Scott | Director | Oct 10 | Grant / award · A | +15,000 | — | — | 15,000 |
Loading...
